Pluripotent stem cells are a class of pluripotent cells with the ability to self-renew indefinitely in vitro and differentiate into various cell types in the body. They are important tools for studying gene function, building disease models and advancing the field of regenerative medicine.
The pluripotency of stem cells is regulated and maintained by transcriptional networks that include a series of pluripotent transcription factors. These pluripotent genes stimulate or inhibit the expression of downstream genes, inducing the occurrence of some signaling pathways and regulating the pluripotency of stem cells.
Stem cells retain the potential for self-renewal and multidirectional differentiation in the action of signaling pathways regulating the pluripotency of stem cells. Having a better understanding of the mechanism of these pathways could help scientists study gene function ＆ disease pathogenesis and promote the development of regenerative medicine.
Human pluripotent stem cells (hPSCs) are originally established on the feeder layer, murine embryo fibroblast (MEF) irradiated or treated with mitomycin. The feeder layer not only provides nutrition for cell growth but also secrets cytokines (Activin A, IGF-2) that synergize with bFGF (basic fibroblast growth factor) in the culture solution to maintain the pluripotency of human stem cells.
Low concentrations of bFGF can maintain the pluripotency of hPSC in the presence of feeder cells. Because the insulin-like growth factor (IGF) induced by bFGF activates the PI3K-AKT signaling pathway, which inhibits the expression of GSK3, inhibiting the degradation of β-Catenin and maintaining the pluripotency of hPSCs.
Besides, Activin/Nodal/TGF-β respectively binds to their receptors on the cell membrane in the presence of bFGF, activating intracellular cytoplasmic SMAD2/SMAD3. Active SMAD2/3 and SMAD4 form heterodimers into the nucleus, regulating the expression of related genes that maintain the pluripotency of hPSCs. SMAD2/3 can be directly conjugated to the proximal promoter region of Nanog to upregulate the expression of this gene. When the expression of Nanog is increased, the expression of SMAD2/3 is inhibited by negative feedback regulation, and Activin/Nodal/TGF-β signaling pathway in hPSC is controlled to ensure that hPSCs cannot be induced to differentiate into mesendoderm.
BMP4 (bone morphognic protein 4) binds to BMPR, phosphorylating cellular SMAD1, SMAD5, and SMAD8 rather than SMAD2/3. Phosphorylated SMAD1/5/8 further binds to SMAD4 and enters into the nucleus to modulate transcription. When BMP4 in the culture solution is not enough to maintain hPSC self-renewing, the BMP4-SMAD1/5/8 signaling upregulates with the differentiation of hPSCs.
|WNT16||WNT16 Antibody||WNT16 Protein||WNT16 cDNA||WNT16 ELISA Kit|
|WNT2||WNT2 Antibody||WNT2 Protein||WNT2 cDNA||WNT2 ELISA Kit|
|WNT2B||WNT2B Antibody||WNT2B Protein||WNT2B cDNA||WNT2B ELISA Kit|
|WNT3||WNT3 Antibody||WNT3 Protein||WNT3 cDNA||WNT3 ELISA Kit|
|WNT3A||WNT3A Antibody||WNT3A Protein||WNT3A cDNA||WNT3A ELISA Kit|
|WNT4||WNT4 Antibody||WNT4 Protein||WNT4 cDNA||WNT4 ELISA Kit|
|WNT5A||WNT5A Antibody||WNT5A Protein||WNT5A cDNA||WNT5A ELISA Kit|
|WNT5B||WNT5B Antibody||WNT5B Protein||WNT5B cDNA||WNT5B ELISA Kit|
|WNT6||WNT6 Antibody||WNT6 Protein||WNT6 cDNA||WNT6 ELISA Kit|
|WNT7A||WNT7A Antibody||WNT7A Protein||WNT7A cDNA||WNT7A ELISA Kit|
|WNT7B||WNT7B Antibody||WNT7B Protein||WNT7B cDNA||WNT7B ELISA Kit|
|WNT8A||WNT8A Antibody||WNT8A Protein||WNT8A cDNA||WNT8A ELISA Kit|
|WNT8B||WNT8B Antibody||WNT8B Protein||WNT8B cDNA||WNT8B ELISA Kit|
|WNT9A||WNT9A Antibody||WNT9A Protein||WNT9A cDNA||WNT9A ELISA Kit|
|WNT9B||WNT9B Antibody||WNT9B Protein||WNT9B cDNA||WNT9B ELISA Kit|
|ZFHX3||ZFHX3 Antibody||ZFHX3 Protein||ZFHX3 cDNA||ZFHX3 ELISA Kit|
|ZIC3||ZIC3 Antibody||ZIC3 Protein||ZIC3 cDNA||ZIC3 ELISA Kit|